Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

0.5551
Delayed Data
As of 3:31pm ET
 -0.0149 / -2.61%
Today’s Change
0.26
Today|||52-Week Range
1.51
-12.93%
Year-to-Date
No recent news for Navidea Biopharmaceuticals Inc.

Today’s Trading

Previous close0.57
Today’s open0.56
Day’s range0.55 - 0.57
Volume335,808
Average volume (3 months)1,095,859
Market cap$88.8M
Dividend yield--
Data as of 3:31pm ET, 03/28/2017

Growth & Valuation

Earnings growth (last year)+25.00%
Earnings growth (this year)+55.56%
Earnings growth (next 5 years)--
Revenue growth (last year)+111.15%
P/E ratioNM
Price/Sales15.18
Price/Book--

Competitors

 Today’s
change
Today’s
% change
SNSSSunesis Pharmaceutic...-0.04-0.95%
SBPHSpring Bank Pharmace...-0.18-1.93%
RGLSRegulus Therapeutics...-0.20-11.76%
EIGREiger BioPharmaceuti...0.000.00%
Data as of 3:49pm ET, 03/28/2017

Financials

Last reporting dateMarch 28, 2017
EPS forecast (this quarter)-$0.01
Annual revenue (last year)$13.2M
Annual profit (last year)-$27.6M
Net profit margin-213.76%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mike M. Goldberg
Chief Operating &
Financial Officer
Jed Andrew Latkin
Corporate headquarters
Dublin, Ohio

Forecasts


Search for Jobs